Skip to main content

CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001042074

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding CymaBay Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CBAY: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders114113−1
Shares46.4M63.8M+17.4M (+37.6%)
Value$169.3M$215.7M+$46.3M (+27.3%)

New holders (24)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CBAY in Q4 2021
InstitutionSharesValue% of portfolio
TCG Crossover Management, LLC5,905,400$20.0M9.35%
Nantahala Capital Management, LLC2,000,142$6.76M0.42%
Altium Capital Management LP1,750,000$5.92M1.66%
Lynx1 Capital Management LP1,224,968$4.14M3.61%
Affinity Asset Advisors, LLC1,122,244$3.79M1.62%
683 Capital Management, LLC1,100,000$3.72M0.18%
Point72 Asset Management, L.P.681,401$2.30M0.01%
Stonepine Capital Management, LLC300,000$1.01M0.47%
Alpine Global Management, LLC250,000$845.0K0.13%
Prosight Management, LP166,775$564.0K0.38%
Sender Co & Partners, Inc.61,080$206.0K0.13%
PDT Partners, LLC58,035$196.0K0.01%
Bridgeway Capital Management, LLC43,500$147.0K0.00%
ExodusPoint Capital Management, LP35,495$120.0K0.00%
Two Sigma Investments, LP28,100$95.0K0.00%
Bank of Nova Scotia14,591$55.0K0.00%
Bailard, Inc.13,700$46.0K0.00%
New York Life Investments Alternatives12,924$44.0K0.03%
Susquehanna International Group, LLP10,845$37.0K0.00%
Dynamic Technology Lab Private Ltd11,074$37.0K0.00%
EverSource Wealth Advisors, LLC1,050$4.00K0.00%
Massmutual Trust Co FSB178$1.00K0.00%
Amplius Wealth Advisors, LLC550$1.00K0.00%
Toronto Dominion Bank8$00.00%

Sold out (25)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.